MENU
+Compare
ITOS
Stock ticker: NASDAQ
AS OF
Jul 2, 04:59 PM (EDT)
Price
$10.16
Change
+$0.19 (+1.91%)
Capitalization
382.55M

ITOS iTeos Therapeutics Forecast, Technical & Fundamental Analysis

ITeos Therapeutics Inc is a biopharmaceutical company... Show more

ITOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for ITOS with price predictions
Jul 01, 2025

ITOS's RSI Oscillator recovers from overbought zone

The 10-day RSI Indicator for ITOS moved out of overbought territory on June 17, 2025. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 24 instances where the indicator moved out of the overbought zone. In of the 24 cases the stock moved lower in the days that followed. This puts the odds of a move down at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on June 27, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on ITOS as a result. In of 82 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for ITOS turned negative on June 11, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 42 similar instances when the indicator turned negative. In of the 42 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ITOS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

The 50-day moving average for ITOS moved above the 200-day moving average on June 25, 2025. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ITOS advanced for three days, in of 267 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 153 cases where ITOS Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ITOS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.679) is normal, around the industry mean (16.395). P/E Ratio (0.000) is within average values for comparable stocks, (58.556). ITOS's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.311). Dividend Yield (0.000) settles around the average of (0.041) among similar stocks. P/S Ratio (12.092) is also within normal values, averaging (259.528).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ITOS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
ITOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

ITOS is expected to report earnings to fall 2.51% to -77 cents per share on August 07

iTeos Therapeutics ITOS Stock Earnings Reports
Q2'25
Est.
$-0.78
Q1'25
Beat
by $0.13
Q4'24
Beat
by $0.04
Q3'24
Beat
by $0.12
Q2'24
Beat
by $0.86
The last earnings report on April 28 showed earnings per share of -80 cents, beating the estimate of -93 cents. With 319.30K shares outstanding, the current market capitalization sits at 382.55M.
A.I. Advisor
published General Information

General Information

a company, which engages in the development of biopharmaceuticals therapeutic products and services

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
321 Arsenal Street
Phone
+1 339 217-0162
Employees
157
Web
https://www.iteostherapeutics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FKYS17.001.65
+10.75%
First Keystone Corp.
VTKLF5.81N/A
N/A
VTech Holdings, Ltd.
CLRSF0.04N/A
N/A
CASTILE RES LTD.
MKTAY30.98-0.12
-0.39%
Makita Corp.
NPPXF1.04-0.12
-10.03%
Nippon Telegraph & Telephone Corp.

ITOS and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ITOS has been loosely correlated with BMRN. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if ITOS jumps, then BMRN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ITOS
1D Price
Change %
ITOS100%
N/A
BMRN - ITOS
50%
Loosely correlated
+2.22%
IMNM - ITOS
45%
Loosely correlated
-8.98%
BDTX - ITOS
44%
Loosely correlated
N/A
IBO - ITOS
44%
Loosely correlated
-0.62%
RCUS - ITOS
42%
Loosely correlated
+2.70%
More